Preview

Nephrology (Saint-Petersburg)

Advanced search
Open Access Open Access  Restricted Access Subscription Access

Disturbances of citrulline homeostasis in patients with arterial hypertension

https://doi.org/10.36485/1561-6274-2024-28-3-47-54

EDN: PXVWTH

Abstract

BACKGROUND. Evaluation the level of citrulline (Cit) in the blood allows us to determine metabolic disorders in the proximal tubules of the kidneys. Previously, we showed that impaired metabolic function of the kidneys in hypertensive patients (AH) is expressed by an increase in the level of Cit. THE AIM was to determine diagnostically significant Cutoff value or exceeding Cit levels in the blood separately for men and women with hypertension. PATIENTS AND METHODS. We examined 115 hyperten sive patients with an estimated glomerular filtration rate ≥ 45 ml/min/1.73 m2, included 44 men and 71 women aged 63 [56; 68] and 64 [53; 73] years, respectively. The comparison group included 30 older age group donors (11 men and 19 women). Determination of the levels of Cit, arginine (Arg) and others was carried out using high-performance liquid chromatography. RESULTS. Metabolic disorders: obesity – noted in 57 % of men and 50 % of women; and hypercholesterolemia in 30 and 33 % and hypertriglyceridemia in 37 and 29 % of patients, respectively. Metabolic dysfunction in the subgroups of men and women, according to Cit content, was expressed by an increase in its levels by an average of 32 and 29 %, respectively. ROC analysis determined the cutoff value for men > 49.1 μM Cit, p = 0.0023, which corresponds to 68 % sensitivity and 91 % specificity, and 46.3 μM (p = 0.0014) with 80 % sensitivity and specificity 63 % for women. CONCLUSION. A slight decrease in the metabolic functions of the kidneys affects Cit homeostasis, which has diagnostic value. According to the data obtained, renal metabolism ensures the content of Cit in the blood – not higher than 49.1 μM in men and women – 46.3 μM, before the onset of a violation of this metabolic function in patients with hypertension.

About the Authors

A. A. Zhloba
Pavlov First Saint Petersburg State Medical University
Russian Federation

Prof. Aleksandr A. Zhloba, MD, PhD, DMedSci, Scientific Research Institute of Biomedicine, Head of the Department of Biochemistry

197022, St-Petersburg, L. Tolstoy st., 6-8, build 3

Phone: (812)338-71-08



T. F. Subbotina
Pavlov First Saint Petersburg State Medical University
Russian Federation

Associate prof. Tatiana F. Subbotina, MD, PhD, DMedSci, Scientific Research Institute of Biomedicine, Head of the Laboratory of Biochemical Monitoring

197022, St-Petersburg, L. Tolstoy st., 6-8, build 3

Phone: (812)338-71-08



References

1. Balashova EE, Trifonova OP, Maslov DL et al. Metabolome profiling in the study of aging processes. Biomed Khim 2022;68(5):321–338. (In Russ.) doi: 10.18097/PBMC20226805321

2. Cañadas-Garre M, Anderson K, McGoldrick J et al. Proteomic and metabolomic approaches in the search for biomarkers in chronic kidney disease. J Proteomics 2019;193:93–122. doi: 10.1016/j.jprot.2018.09.020

3. Gervasini G, Verde Z, González LM et al. Prognostic significance of amino acid and biogenic amines profiling in chronic kidney disease. Biomedicines 2023;11(10):2775. doi: 10.3390/biomedicines11102775

4. Yin Y, Shan C, Han Q et al. Causal effects of human serum metabolites on occurrence and progress indicators of chronic kidney disease: a two-sample Mendelian randomization study. Front Nutr 2024;10:1274078. doi: 10.3389/fnut.2023.1274078

5. Korol L, Stepanova N, Vasylchenko V. #612 Serum citrulline level is associated with oxidative stress and chronic kidney disease progression. Nephr Dial Transpl 2024;39(Suppl_1):gf ae069–1382–612. doi: 10.1093/ndt/gfae069.1382

6. Rabier D, Kamoun P. Metabolism of citrulline in man. Amino Acids 1995;9:299–316. doi: 10.1007/BF00807268

7. Aguayo E, Martínez-Sánchez A, Fernández-Lobato B, Alacid F. L-citrulline: a non-essential amino acid with important roles in human health. Appl Sci 2021;11(7):3293. doi: 10.3390/app11073293

8. Pillai SM, Seebeck P, Fingerhut R et al. Kidney mass reduction leads to l-arginine metabolism-dependent blood pressure increase in mice. J Am Heart Assoc 2018;7(5):e008025. doi: 10.1161/JAHA.117.008025

9. Chen GF, Baylis C. In vivo renal arginine release is impaired throughout development of chronic kidney disease. Am J Physiol Renal Physiol 2010;298(1):F95–102. doi: 10.1152/ajprenal.00487.2009

10. Brosnan ME, Brosnan JT. Renal arginine metabolism. J Nutr 2004;134(10 Suppl):2791S–2795S; discussion 2796S–2797S. doi: 10.1093/jn/134.10.2791S

11. Zhloba AA, Subbotina TF, Reypolskaya TYu. The level of blood citrulline in hypertensive patients with abnormal renal excretory function. Klin Lab Diagn 2023;68(3):133–140. (In Russ.) doi: 10.51620/0869-2084-2023-68-3-133-140

12. Zhloba AA, Subbotina TF, Shipaeva KA. The way for determining the content of homoarginine in blood plasma and other biological fluids of human. Patent RF N 2609873; 2017. (In Russ.)

13. Zhloba AA, Subbotina TF. Homocysteinylation score of high molecular weight plasma proteins. Amino Acids 2014;46(4):893–899. doi: 10.1007/s00726-013-1652-4

14. Tietz NW, ed. Clinical Guide to Laboratory Tests. WB Saunders, Philadelphia, 1983. (In Russ.)

15. Zhloba AA, Subbotina TF. The evaluation of folate status using total homocysteine in hypertensive patients. Ross med zhurn 2019;25(3):158–165. (In Russ.) doi: 10.18821/0869-2106-2019-25-3-158-165

16. Rougé C, Des Robert C, Robins A et al. Manipulation of citrulline availability in humans. Am J Physiol Gastrointest Liver Physiol 2007;293(5):G1061–7. doi: 10.1152/ajpgi.00289.2007


Review

For citations:


Zhloba A.A., Subbotina T.F. Disturbances of citrulline homeostasis in patients with arterial hypertension. Nephrology (Saint-Petersburg). 2024;28(3):47-54. (In Russ.) https://doi.org/10.36485/1561-6274-2024-28-3-47-54. EDN: PXVWTH

Views: 155


ISSN 1561-6274 (Print)
ISSN 2541-9439 (Online)